Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

ESMO WCGIC 2020 | CAIRO6: perioperative systemic therapy for resectable colorectal peritoneal metastases

Ignace H.J.T. de Hingh and Koen Rovers • 21 Jun 2020
ESMO WCGIC 2020
Colorectal Cancer Gastrointestinal Cancer Antibodies Bevacizumab
CAIRO6

Ignace H.J.T. de Hingh MD, PhD and Koen Rovers, MD, of the Catharina Hospital, Eindhoven, The Netherlands, discuss the outcomes of the CAIRO6 study (NCT02758951), evaluating safety, feasibility, tolerability, and preliminary efficacy of perioperative systemic therapy for resectable colorectal peritoneal metastases. This interview was recorded via an online conference call with The Video Journal of Oncology (VJOncology).

More from Ignace H.J.T. de Hingh

2:01
Propensity score-matched analysis of adjuvant chemo after resection of colorectal peritoneal mets
Ignace H.J.T. de Hingh et al. • 3 Jul 2020

More from Koen Rovers

2:01
Propensity score-matched analysis of adjuvant chemo after resection of colorectal peritoneal mets
Ignace H.J.T. de Hingh et al. • 3 Jul 2020

Related Videos

1:53
Important pathophysiological determinants of elevated cirDNA post-surgery
Alain Thierry • 9 Apr 2024
0:47
Emerging molecular drivers and biomarker targets in gastroesophageal cancers
Tatsuhiro Shibata • 9 Apr 2024
0:52
DRP-104 with durvalumab in fibrolamellar hepatocellular carcinoma
Marina Baretti • 9 Apr 2024
1:06
The emerging role of cancer vaccines in treating liver cancer
Marina Baretti • 9 Apr 2024
The content of VJOncology is intended for healthcare professionals